Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
26.21
+0.04 (0.15%)
At close: Jun 12, 2026, 4:00 PM EDT
26.19
-0.02 (-0.08%)
After-hours: Jun 12, 2026, 7:59 PM EDT
Pfizer Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 7,523 | 7,787 | 8,051 | 2,173 | 31,401 | 22,459 |
Depreciation & Amortization | 6,587 | 6,592 | 7,013 | 6,290 | 5,064 | 5,191 |
Stock-Based Compensation | 901 | 799 | 877 | 525 | 872 | 1,182 |
Other Adjustments | 2,143 | 1,881 | -132 | 1,886 | -2,431 | -8,713 |
Change in Receivables | - | -263 | -109 | 347 | 261 | -3,811 |
Changes in Inventories | - | 561 | -854 | -1,169 | -591 | -1,125 |
Changes in Accounts Payable | - | -469 | -1,023 | -300 | 1,191 | 1,242 |
Changes in Accrued Expenses | - | -3,667 | -3,115 | 595 | -1,449 | 18,721 |
Changes in Income Taxes Payable | - | -2,805 | -1,345 | -982 | -545 | -1,166 |
Changes in Other Operating Activities | -6,757 | 1,289 | 3,380 | -663 | -4,506 | -1,057 |
Operating Cash Flow | 11,984 | 11,704 | 12,744 | 8,700 | 29,267 | 32,580 |
Operating Cash Flow Growth | -14.33% | -8.16% | 46.48% | -70.27% | -10.17% | 126.20% |
Capital Expenditures | -2,501 | -2,629 | -2,909 | -3,907 | -3,236 | -2,711 |
Purchases of Investments | -14,366 | -14,650 | -10,313 | -31,178 | -38,297 | -39,525 |
Proceeds from Sale of Investments | 19,681 | 19,054 | 5,698 | 41,243 | 45,462 | 28,096 |
Payments for Business Acquisitions | - | -6,927 | - | -43,430 | -22,997 | - |
Proceeds from Business Divestments | - | 6,311 | 7,040 | - | - | - |
Other Investing Activities | 272 | -2,510 | 3,138 | 4,995 | 3,285 | -8,393 |
Investing Cash Flow | -3,840 | -1,351 | 2,652 | -32,278 | -15,783 | -22,546 |
Short-Term Debt Issued | -537 | -796 | 6,317 | 7,686 | 3,669 | -96 |
Short-Term Debt Repaid | -151 | -2,199 | -11,226 | -3 | -3,887 | - |
Net Short-Term Debt Issued (Repaid) | -688 | -2,995 | -4,909 | 7,683 | -218 | -96 |
Long-Term Debt Issued | 2,953 | 2,921 | -2,250 | 28,262 | -3,298 | -1,007 |
Net Long-Term Debt Issued (Repaid) | 2,953 | 2,921 | -2,250 | 28,262 | -3,298 | -1,007 |
Repurchase of Common Stock | - | - | - | - | -2,000 | - |
Net Common Stock Issued (Repurchased) | - | - | - | - | -2,000 | - |
Common Dividends Paid | -9,779 | -9,771 | -9,512 | -9,247 | -8,983 | -8,729 |
Other Financing Activities | -386 | -458 | -469 | -631 | -335 | 16 |
Financing Cash Flow | -7,933 | -10,304 | -17,140 | 26,066 | -14,834 | -9,816 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 67 | 41 | -66 | -40 | -165 | -59 |
Net Cash Flow | 279 | 91 | -1,810 | 2,448 | -1,515 | 159 |
Free Cash Flow | 9,483 | 9,075 | 9,835 | 4,793 | 26,031 | 29,869 |
Free Cash Flow Growth | 4.50% | -7.73% | 105.19% | -81.59% | -12.85% | 145.29% |
FCF Margin | 14.98% | 14.50% | 15.46% | 8.05% | 25.73% | 36.74% |
Free Cash Flow Per Share | 1.66 | 1.59 | 1.73 | 0.84 | 4.54 | 5.23 |
Levered Free Cash Flow | 7,084 | 6,569 | 2,019 | 37,928 | 23,784 | 39,971 |
Unlevered Free Cash Flow | 4,850 | 6,658 | 9,198 | 2,035 | 27,327 | 41,554 |